The past year has seen several merger attempts by large pharmaceutical companies. Executive Director Saikat Chaudhuri weighs in on the motives behind these deals.…Read More
The Real Motive Behind Big Pharma Mergers
pharmaceutical industry
Decoding the Adaptability-Rigidity Puzzle: Evidence from Pharmaceutical Incumbents’ Pursuit of Gene Therapy and Monoclonal Antibodies
The emergence of radical technologies presents a significant challenge to incumbent firms. We study firms’ management of radical technological change by separating their actions into upstream research (“R” of R&D) and downstream development (“D” of R&D).…Read More
Portfolio Management in New Drug Development
The pharmaceutical industry leads all industries in terms of R&D spend. Portfolio management in new drug development is extremely challenging due to long drug development cycles and high probabilities of failure.…Read More